342 related articles for article (PubMed ID: 23690668)
1. Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases.
Bonacina F; Baragetti A; Catapano AL; Norata GD
Mediators Inflamm; 2013; 2013():725102. PubMed ID: 23690668
[TBL] [Abstract][Full Text] [Related]
2. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.
Norata GD; Garlanda C; Catapano AL
Trends Cardiovasc Med; 2010 Feb; 20(2):35-40. PubMed ID: 20656213
[TBL] [Abstract][Full Text] [Related]
3. The yin-yang of long pentraxin PTX3 in inflammation and immunity.
Daigo K; Mantovani A; Bottazzi B
Immunol Lett; 2014 Sep; 161(1):38-43. PubMed ID: 24792672
[TBL] [Abstract][Full Text] [Related]
4. The long pentraxin PTX3 in vascular pathology.
Mantovani A; Garlanda C; Bottazzi B; Peri G; Doni A; Martinez de la Torre Y; Latini R
Vascul Pharmacol; 2006 Nov; 45(5):326-30. PubMed ID: 17023219
[TBL] [Abstract][Full Text] [Related]
5. Pattern recognition by pentraxins.
Agrawal A; Singh PP; Bottazzi B; Garlanda C; Mantovani A
Adv Exp Med Biol; 2009; 653():98-116. PubMed ID: 19799114
[TBL] [Abstract][Full Text] [Related]
6. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.
Bottazzi B; Vouret-Craviari V; Bastone A; De Gioia L; Matteucci C; Peri G; Spreafico F; Pausa M; D'Ettorre C; Gianazza E; Tagliabue A; Salmona M; Tedesco F; Introna M; Mantovani A
J Biol Chem; 1997 Dec; 272(52):32817-23. PubMed ID: 9407058
[TBL] [Abstract][Full Text] [Related]
7. Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation.
Deban L; Bottazzi B; Garlanda C; de la Torre YM; Mantovani A
Biofactors; 2009; 35(2):138-45. PubMed ID: 19449441
[TBL] [Abstract][Full Text] [Related]
8. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response.
Garlanda C; Hirsch E; Bozza S; Salustri A; De Acetis M; Nota R; Maccagno A; Riva F; Bottazzi B; Peri G; Doni A; Vago L; Botto M; De Santis R; Carminati P; Siracusa G; Altruda F; Vecchi A; Romani L; Mantovani A
Nature; 2002 Nov; 420(6912):182-6. PubMed ID: 12432394
[TBL] [Abstract][Full Text] [Related]
9. The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases.
Jaillon S; Bonavita E; Gentile S; Rubino M; Laface I; Garlanda C; Mantovani A
Int Arch Allergy Immunol; 2014; 165(3):165-78. PubMed ID: 25531094
[TBL] [Abstract][Full Text] [Related]
10. The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling.
Inforzato A; Jaillon S; Moalli F; Barbati E; Bonavita E; Bottazzi B; Mantovani A; Garlanda C
Tissue Antigens; 2011 Apr; 77(4):271-82. PubMed ID: 21388349
[TBL] [Abstract][Full Text] [Related]
11. Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology.
Oggioni M; Mercurio D; Minuta D; Fumagalli S; Popiolek-Barczyk K; Sironi M; Ciechanowska A; Ippati S; De Blasio D; Perego C; Mika J; Garlanda C; De Simoni MG
Sci Rep; 2021 May; 11(1):9616. PubMed ID: 33953334
[TBL] [Abstract][Full Text] [Related]
12. Biological actions of pentraxins.
Vilahur G; Badimon L
Vascul Pharmacol; 2015 Oct; 73():38-44. PubMed ID: 25962566
[TBL] [Abstract][Full Text] [Related]
13. Pentraxins and atherosclerosis: the role of PTX3.
Garlanda C; Bottazzi B; Moalli F; Deban L; Molla F; Latini R; Mantovani A
Curr Pharm Des; 2011; 17(1):38-46. PubMed ID: 21226667
[TBL] [Abstract][Full Text] [Related]
14. The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules.
Mantovani A; Valentino S; Gentile S; Inforzato A; Bottazzi B; Garlanda C
Ann N Y Acad Sci; 2013 May; 1285():1-14. PubMed ID: 23527487
[TBL] [Abstract][Full Text] [Related]
15. Expression and Purification of Full-Length and Domain-Fragment Recombinant Pentraxin 3 (PTX3) Proteins from Mammalian and Bacterial Cells.
Daigo K; Hamakubo T
Methods Mol Biol; 2020; 2132():65-74. PubMed ID: 32306315
[TBL] [Abstract][Full Text] [Related]
16. The Dual Complexity of PTX3 in Health and Disease: A Balancing Act?
Magrini E; Mantovani A; Garlanda C
Trends Mol Med; 2016 Jun; 22(6):497-510. PubMed ID: 27179743
[TBL] [Abstract][Full Text] [Related]
17. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.
Mantovani A; Garlanda C; Doni A; Bottazzi B
J Clin Immunol; 2008 Jan; 28(1):1-13. PubMed ID: 17828584
[TBL] [Abstract][Full Text] [Related]
18. Pentraxins as a key component of innate immunity.
Bottazzi B; Garlanda C; Salvatori G; Jeannin P; Manfredi A; Mantovani A
Curr Opin Immunol; 2006 Feb; 18(1):10-5. PubMed ID: 16343883
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population.
Baragetti A; Knoflach M; Cuccovillo I; Grigore L; Casula M; Garlaschelli K; Mantovani A; Wick G; Kiechl S; Willeit J; Bottazzi B; Catapano AL; Norata GD
Nutr Metab Cardiovasc Dis; 2014 May; 24(5):518-23. PubMed ID: 24462365
[TBL] [Abstract][Full Text] [Related]
20. Pentraxins: CRP and PTX3 and cardiovascular disease.
Maekawa Y; Nagai T; Anzai A
Inflamm Allergy Drug Targets; 2011 Aug; 10(4):229-35. PubMed ID: 21539513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
